When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBRX - Moleculin to conduct in vivo for WP1122 in COVID-19
Moleculin Biotech Inc.
Moleculin Biotech (NASDAQ:MBRX) has contracted with an independent laboratory to test the antiviral activity of its WP1122 portfolio in a COVID-19 animal model.
More news on: Moleculin Biotech, Inc., Healthcare stocks news, Stocks on the move,